Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v11-FR Version v5-FR
Language French French
Date Updated 2021-01-28 2020-09-24
Drug Identification Number 02241709 02241709
Brand name TEVA-CLINDAMYCIN TEVA-CLINDAMYCIN
Common or Proper name TEVA-CLINDAMYCIN 150MG CAPSULES TEVA-CLINDAMYCIN 150MG CAPSULES
Company Name TEVA CANADA LIMITED TEVA CANADA LIMITED
Ingredients CLINDAMYCIN CLINDAMYCIN
Strength(s) 150MG 150MG
Dosage form(s) CAPSULE CAPSULE
Route of administration ORAL ORAL ORAL ORAL
Packaging size 100 100
ATC code J01FF J01FF
ATC description MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2020-08-20 2020-08-20
Estimated end date 2021-02-28 2020-10-31
Actual end date 2021-01-27
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments